Roivant Sciences's total assets for Q1 2026 were $5.31B, a decrease of -7.36% from the previous quarter. DE:87S total liabilities were $384.62M for the fiscal quarter, a -11.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.